Modality Dx Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $16.6M

  • Investors
  • 7

Modality Dx General Information

Description

Developer of a medical diagnostics test technology designed to offer test kits for early detection of diabetes and latent autoimmune diabetes in adults. The company's technology measures total saliva glycosylated protein levels to estimate recent average blood glucose levels and also offers the pregnancy metabolic profile to estimate the risk of preeclampsia and gestational diabetes in expectant mothers, enabling professionals to access efficient technology for early diabetes detection.

Contact Information

Formerly Known As
DiabetOmics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2345 North East Overlook Drive
  • Suite Number 140
  • Hillsboro, OR 97006
  • United States
+1 (503)
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Corporate Office
  • 2345 North East Overlook Drive
  • Suite Number 140
  • Hillsboro, OR 97006
  • United States
+1 (503)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Modality Dx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series E) 15-Jul-2020 $16.6M Completed Generating Revenue
5. Later Stage VC (Series D) 19-Jan-2018 Completed Generating Revenue
4. Later Stage VC (Series C1) 12-Mar-2015 Completed Generating Revenue
3. Later Stage VC (Series C) 24-Oct-2014 Completed Generating Revenue
2. Grant 31-Jul-2013 $733K $4.2M Completed Generating Revenue
1. Early Stage VC (Series A) 11-Oct-2011 $4.2M $4.2M Completed Generating Revenue
To view Modality Dx’s complete valuation and funding history, request access »

Modality Dx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C1
Series C
Series B 1,000,000 $9.39 $9.39 1x $9.39 10.23%
Series A 2,000,000 $2.5 $2.5 1x $2.5 20.45%
To view Modality Dx’s complete cap table history, request access »

Modality Dx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical diagnostics test technology designed to offer test kits for early detection of diabetes and laten
Diagnostic Equipment
Hillsboro, OR
11 As of 2026

Shanghai, China
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Modality Dx Competitors (17)

One of Modality Dx’s 17 competitors is Medtrum, a Venture Capital-Backed company based in Shanghai, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medtrum Venture Capital-Backed Shanghai, China
GlySure Formerly VC-backed London, United Kingdom
Microlife Private Equity-Backed Taipei, Taiwan
Indigo (Monitoring Equipment) Venture Capital-Backed Gent, Belgium
Bigfoot Biomedical Formerly VC-backed Milpitas, CA
You’re viewing 5 of 17 competitors. Get the full list »

Modality Dx Patents

Modality Dx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4259818-A1 Systems and methods for rheumatoid arthritis biomarker detection Pending 10-Dec-2020
EP-4259818-A4 Systems and methods for rheumatoid arthritis biomarker detection Pending 10-Dec-2020
US-20250264466-A1 Systems and methods for rheumatoid arthritis biomarker detection Pending 10-Dec-2020
WO-2022125972-A1 Systems and methods for rheumatoid arthritis biomarker detection Inactive 10-Dec-2020
WO-2022125972-A8 Systems and methods for rheumatoid arthritis biomarker detection Inactive 10-Dec-2020 G01N33/564
To view Modality Dx’s complete patent history, request access »

Modality Dx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Modality Dx Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
VenturEast Venture Capital Minority
Harrison School District 2 Corporation Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 7 investors. Get the full list »

Modality Dx FAQs

  • When was Modality Dx founded?

    Modality Dx was founded in 2008.

  • Where is Modality Dx headquartered?

    Modality Dx is headquartered in Hillsboro, OR.

  • What is the size of Modality Dx?

    Modality Dx has 11 total employees.

  • What industry is Modality Dx in?

    Modality Dx’s primary industry is Diagnostic Equipment.

  • Is Modality Dx a private or public company?

    Modality Dx is a Private company.

  • What is the current valuation of Modality Dx?

    The current valuation of Modality Dx is .

  • What is Modality Dx’s current revenue?

    The current revenue for Modality Dx is .

  • How much funding has Modality Dx raised over time?

    Modality Dx has raised $77.8M.

  • Who are Modality Dx’s investors?

    , VenturEast, Harrison School District 2, , and are 5 of 7 investors who have invested in Modality Dx.

  • Who are Modality Dx’s competitors?

    Medtrum, GlySure, Microlife, Indigo (Monitoring Equipment), and Bigfoot Biomedical are some of the 17 competitors of Modality Dx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process